QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,148 signal articles · 499 in last 24h · 103,980 total before filter · latest 35m ago
499last 24h
2495last 7d
474● bullish (7d)
247● bearish (7d)
198publishers
AllMacro218Earnings1485M&A144Regulatory15Product5Analyst29
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Gilead Sciences (NASDAQ:GILD) Beats Expectations in Strong Q2 CY2026
StockStory23h agobullish
Gilead Sciences (NASDAQ:GILD) Beats Expectations in Strong Q2 CY2026

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 10.2% year on year to $7.80 billion. On the other hand, the company’s full-year revenue guidance of $30.25 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP loss of $6.75 per share was 6.9% above analysts’ consensus estimates.

Lucid Sales Top Estimates. The Stock Is Down.
Barrons.com23h agoneutral
Lucid Sales Top Estimates. The Stock Is Down.

Wall Street was looking for sales of $361 million and a gross loss of $311 million, according to FactSet. The company delivered 3,953 vehicles in the second quarter, up from 3,309 cars a year ago. Selling more new Gravity SUVs helped boost sales volume.

Caterpillar Q2 Earnings Call Highlights
MarketBeat23h agoneutral
Caterpillar Q2 Earnings Call Highlights

Caterpillar (NYSE:CAT) reported record second-quarter sales and revenues of $20.5 billion, up 24% from a year earlier, as demand increased across its Construction Industries, Resource Industries and Power & Energy segments. The company said it was the first quarter in its history with more than

Paramount (NASDAQ:PSKY) Posts Better-Than-Expected Sales In Q2 CY2026
StockStory23h agoneutral
Paramount (NASDAQ:PSKY) Posts Better-Than-Expected Sales In Q2 CY2026

Multinational media and entertainment corporation Paramount (NASDAQ:PSKY) reported Q2 CY2026 results beating Wall Street’s revenue expectations, but sales were flat year on year at $6.91 billion. The company expects next quarter’s revenue to be around $7.05 billion, close to analysts’ estimates. Its non-GAAP profit of $0.18 per share was in line with analysts’ consensus estimates.